Works matching AU Denduluri, Neelima

Results: 21

A Novel Case of Bisphosphonate-Related Osteonecrosis of the Torus Palatinus in a Patient with Metastatic Breast Cancer.

Published in:

Oncology, 2006, v. 71, n. 3/4, p. 306, doi. 10.1159/000106451

By:

Goldman, Matthew L.;
Denduluri, Neelima;
Berman, Arlene W.;
Sausville, Rebecca;
Guadagnini, Jean-Pierre;
Kleiner, David E.;
Brahim, Jaime S.;
Swain, Sandra M.

Publication type:

Article

Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer.

Published in:

2020

By:

Crawford, Jeffrey;
Denduluri, Neelima;
Patt, Debra;
Jiao, Xiaolong;
Morrow, Phuong Khanh;
Garcia, Jacob;
Barron, Richard;
Lyman, Gary H.

Publication type:

journal article

Retrospective Observational Study of Outcomes in HER2-Positive Metastatic Breast Cancer (mBC) Patients Treated with Ado-Trastuzumab Emtansine (T-DM1) and Subsequent Treatments After T-DM1 in the United States.

Published in:

Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 177, doi. 10.1007/s40801-022-00340-4

By:

Denduluri, Neelima;
Espirito, Janet L.;
Hackshaw, Michelle D.;
Wentworth, Chuck;
Recchia, Tamy;
Kwong, Winghan J.

Publication type:

Article

Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score.

Published in:

Clinical Breast Cancer, 2020, v. 20, n. 2, p. 125, doi. 10.1016/j.clbc.2019.07.004

By:

Casasanta, Nicole;
Kipnis, Sarit T.;
Linville, Laura;
Lipinski, Shawn;
Knoedler, Alice;
Marino, Amy;
McHenry, Allision;
Biagi, Tara;
Stark, Elizabeth;
Amdur, Richard;
Denduluri, Neelima;
Rodriguez, Patricia;
Isaacs, Claudine;
Kaltman, Rebecca

Publication type:

Article

Chemotherapy Dose Intensity and Overall Survival Among Patients With Advanced Breast or Ovarian Cancer.

Published in:

2018

By:

Denduluri, Neelima;
Lyman, Gary H.;
Yunfei Wang;
Phuong Khanh Morrow;
Barron, Richard;
Patt, Debra;
Bhowmik, Debajyoti;
Xiaoyan Li;
Bhor, Menaka;
Fox, Patricia;
Dhanda, Rahul;
Saravanan, Shanmugapriya;
Xiaolong Jiao;
Garcia, Jacob;
Crawford, Jeffrey;
Wang, Yunfei;
Morrow, Phuong Khanh;
Li, Xiaoyan;
Jiao, Xiaolong

Publication type:

journal article

Patient Case Lessons: Endocrine Management of Advanced Breast Cancer.

Published in:

2018

By:

Robert, Nicholas J.;
Denduluri, Neelima

Publication type:

journal article

Ixabepilone: Clinical Role in Metastatic Breast Cancer.

Published in:

Clinical Breast Cancer, 2011, v. 11, n. 3, p. 139, doi. 10.1016/j.clbc.2011.03.009

By:

Denduluri, Neelima;
Swain, Sandra

Publication type:

Article

Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.

Published in:

2024

By:

Lynce, Filipa;
Mainor, Candace;
Donahue, Renee N.;
Geng, Xue;
Jones, Greg;
Schlam, Ilana;
Wang, Hongkun;
Toney, Nicole J.;
Jochems, Caroline;
Schlom, Jeffrey;
Zeck, Jay;
Gallagher, Christopher;
Nanda, Rita;
Graham, Deena;
Stringer-Reasor, Erica M.;
Denduluri, Neelima;
Collins, Julie;
Chitalia, Ami;
Tiwari, Shruti;
Nunes, Raquel

Publication type:

Correction Notice

Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46961-x

By:

Lynce, Filipa;
Mainor, Candace;
Donahue, Renee N.;
Geng, Xue;
Jones, Greg;
Schlam, Ilana;
Wang, Hongkun;
Toney, Nicole J.;
Jochems, Caroline;
Schlom, Jeffrey;
Zeck, Jay;
Gallagher, Christopher;
Nanda, Rita;
Graham, Deena;
Stringer-Reasor, Erica M.;
Denduluri, Neelima;
Collins, Julie;
Chitalia, Ami;
Tiwari, Shruti;
Nunes, Raquel

Publication type:

Article

Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46961-x

By:

Lynce, Filipa;
Mainor, Candace;
Donahue, Renee N.;
Geng, Xue;
Jones, Greg;
Schlam, Ilana;
Wang, Hongkun;
Toney, Nicole J.;
Jochems, Caroline;
Schlom, Jeffrey;
Zeck, Jay;
Gallagher, Christopher;
Nanda, Rita;
Graham, Deena;
Stringer-Reasor, Erica M.;
Denduluri, Neelima;
Collins, Julie;
Chitalia, Ami;
Tiwari, Shruti;
Nunes, Raquel

Publication type:

Article

Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer.

Published in:

Investigational New Drugs, 2007, v. 25, n. 1, p. 63, doi. 10.1007/s10637-006-9006-7

By:

Neelima Denduluri;
James Lee;
Janice Walshe;
Arlene Berman;
Ujala Vatas;
Catherine Chow;
Seth Steinberg;
Michael Cox;
Jennifer Low;
Sandra Swain

Publication type:

Article

BRCA1/2 mutations and risk‐reducing bilateral salpingo‐oophorectomy among Latinas: The UPTAKE study.

Published in:

Journal of Genetic Counseling, 2021, v. 30, n. 2, p. 383, doi. 10.1002/jgc4.1322

By:

Lynce, Filipa;
Schlam, Ilana;
Geng, Xue;
Peshkin, Beth N.;
Friedman, Sue;
Dutil, Julie;
Nahleh, Zeina;
Campos, Claudia;
Ricker, Charité;
Rodriguez, Patricia;
Denduluri, Neelima;
Ahn, Jaeil;
Isaacs, Claudine;
Graves, Kristi D.

Publication type:

Article

Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study.

Published in:

2020

By:

Mandelblatt, Jeanne S.;
Zhai, Wanting;
Ahn, Jaeil;
Small, Brent J.;
Ahles, Tim A.;
Carroll, Judith E.;
Denduluri, Neelima;
Dilawari, Asma;
Extermann, Martine;
Graham, Deena;
Hurria, Arti;
Isaacs, Claudine;
Jacobsen, Paul B.;
Jim, Heather S. L.;
Luta, George;
McDonald, Brenna C.;
Patel, Sunita K.;
Root, James C.;
Saykin, Andrew J.;
Tometich, Danielle B.

Publication type:

journal article

Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: Interaction with genotype.

Published in:

2019

By:

Carroll, Judith E.;
Small, Brent J.;
Tometich, Danielle B.;
Zhai, Wanting;
Zhou, Xingtao;
Luta, George;
Ahles, Tim A.;
Saykin, Andrew J.;
Nudelman, Kelly N. H.;
Clapp, Jonathan D.;
Jim, Heather S.;
Jacobsen, Paul B.;
Hurria, Arti;
Graham, Deena;
McDonald, Brenna C.;
Denduluri, Neelima;
Extermann, Martine;
Isaacs, Claudine;
Dilawari, Asma A.;
Root, James

Publication type:

journal article

Efficacy/Safety of Talazoparib or Physician's Choice of Therapy in US Patients with HER2-Negative Germline BRCA1/2-Mutated Locally Advanced/Metastatic Breast Cancer (EMBRACA).

Published in:

Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 11, p. 501

By:

Diab, Sami;
Rugo, Hope S.;
Mina, Lida A.;
Puhalla, Shannon;
Mahtani, Reshma;
Henry, N. Lynn;
Denduluri, Neelima;
Yardley, Denise;
Yao Wang;
Shahied Arruda, Lillian;
Tudor, Iulia C.;
Gauthier, Eric;
Czibere, Akos;
Litton, Jennifer K.;
Hurvitz, Sara A.

Publication type:

Article

When to Add Additional Anti-HER2 Therapy to Adjuvant Trastuzumab.

Published in:

Current Oncology Reports, 2019, v. 21, n. 12, p. 1, doi. 10.1007/s11912-019-0848-5

By:

Zimmer, Alexandra S.;
Denduluri, Neelima

Publication type:

Article

The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifen.

Published in:

Breast Cancer Research & Treatment, 2025, v. 211, n. 1, p. 261, doi. 10.1007/s10549-025-07644-3

By:

Safgren, Stephanie L.;
Suman, Vera J.;
Leon Ferre, Roberto A.;
Kosel, Matthew L.;
Stearns, Vered;
Henry, N. Lynn;
Denduluri, Neelima;
Irvin, William;
Ingle, James N.;
Sideras, Kostantinos;
Ames, Matthew M.;
Reid, Joel M.;
Loprinzi, Charles L.;
Black, John L.;
Weinshilboum, Richard M.;
Goetz, Matthew P.

Publication type:

Article

AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers.

Published in:

NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00360-5

By:

Abu-Khalaf, Maysa M.;
Alex Hodge, K.;
Hatzis, Christos;
Baldelli, Elisa;
El Gazzah, Emna;
Valdes, Frances;
Sikov, William M.;
Mita, Monica M.;
Denduluri, Neelima;
Murphy, Rita;
Zelterman, Daniel;
Liotta, Lance;
Dunetz, Bryant;
Dunetz, Rick;
Petricoin, Emanuel F.;
Pierobon, Mariaelena

Publication type:

Article

PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.

Published in:

2019

By:

Chia, Stephen K. L.;
Martin, Miguel;
Holmes, Frankie A.;
Ejlertsen, Bent;
Delaloge, Suzette;
Moy, Beverly;
Iwata, Hiroji;
von Minckwitz, Gunter;
Mansi, Janine;
Barrios, Carlos H.;
Gnant, Michael;
Tomašević, Zorica;
Denduluri, Neelima;
Šeparović, Robert;
Kim, Sung-Bae;
Jakobsen, Erik Hugger;
Harvey, Vernon;
Robert, Nicholas;
Smith II, John;
Harker, Graydon

Publication type:

journal article

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR<sup>+</sup>, HER2<sup>-</sup> breast cancer that had progressed during or after prior endocrine therapy.

Published in:

2017

By:

Musolino, Antonino;
Campone, Mario;
Neven, Patrick;
Denduluri, Neelima;
Barrios, Carlos H.;
Cortes, Javier;
Blackwell, Kimberly;
Soliman, Hatem;
Kahan, Zsuzsanna;
Bonnefoi, Hervé;
Squires, Matthew;
Zhang, Yong;
Deudon, Stephanie;
Shi, Michael M.;
André, Fabrice

Publication type:

journal article

Serum Erythropoietin and Aging: A Longitudinal Analysis.

Published in:

Journal of the American Geriatrics Society, 2005, v. 53, n. 8, p. 1360, doi. 10.1111/j.1532-5415.2005.53416.x

By:

Ershler, William B.;
Sheng, Shan;
McKelvey, Julie;
Artz, Andrew S.;
Denduluri, Neelima;
Tecson, Josephine;
Taub, Dennis D.;
Brant, Larry J.;
Ferrucci, Luigi;
Longo, Dan L.

Publication type:

Article